Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective.

ABSTRACT: High clinical value national reimbursement anticancer medications (NRAMs) are pivotal treatments for patients with cancer. However, the availability of NRAMs in medical institutions is unknown. This study aimed to assess the availability of NRAMs in national and provincial medical institutions. This cross-sectional study utilized national health insurance data to access the availability of NRAMs in national and provincial medical institutions. Further statistical analyses and visualizations were conducted in terms of medical institution level and daily cost. Using the Spearman's rank correlation test (α = 0.05), we calculated the correlation between the availability rates of NRAMs and their negotiation access time, daily cost, per capita disposable income, provincial gross product, and num

SUBMITTER: Meng W 

PROVIDER: S-EPMC11337886 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature